Lung cancer trials in Australia
164 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleVentilation Imaging to Improve the Quality of Life for Patients With Lung Cancer Treated With Radiation Therapy
- Where
- Liverpool
- Age
- 18 years and over
- People
- 165
- Run by
- University of Sydney
See details and how to joinNCT06127654 - No phaseTaking peopleVentilation Using Radiographic Examination: Functional Lung Imaging Techniques for the Reduction of Toxicity in Functional Avoidance Radiation Therapy
- Where
- St Leonards
- Age
- 18 years and over
- People
- 15
- Run by
- University of Sydney
See details and how to joinNCT06159660 - Phase 2Taking peopleSafety and Preliminary Efficacy of Pumitamig (BNT327), an Investigational Therapy for Patients With Non-small Cell Lung Cancer in Combination With Chemotherapy as First-line or Second-line Treatment
- Where
- Adelaide, Hobart, Liverpool, Nedlands, Woolloongabba
- Age
- 18 years and over
- People
- 60 worldwide
- Run by
- BioNTech SE
See details and how to joinNCT06841055 · EU 2024-518279-80-00 - Phase 3Taking peopleJoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer
- Where
- Fitzroy, Geelong
- Age
- 18 years and over
- People
- 272 worldwide
- Run by
- University of Texas Southwestern Medical Center
See details and how to joinNCT02468024 - Phase 1Taking peoplePhase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC
- Where
- Adelaide, Heidelberg, Nedlands
- Age
- 18 years and over
- People
- 304 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT04686305 · EU 2023-504949-31-00 - Phase 1/2Taking peopleEarly Phase Study of KESONOTIDE™in Participants With Solid Tumours
- Where
- Kogarah, Liverpool, Miranda
- Age
- 18 years and over
- People
- 80
- Run by
- Filamon LTD
See details and how to joinNCT06926075 - No phaseTaking peopleThe MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
- Where
- Melbourne
- Age
- 18 years and over
- People
- 8,000 worldwide
- Run by
- UMC Utrecht
See details and how to joinNCT04075305 - No phaseTaking peopleEarly Feasibility Study (EFS) of the 'CAROL' for Treatment of Lung Cancer Stage 1
- Where
- Melbourne
- Age
- 18 years and over
- People
- 7
- Run by
- Tau Medical Australia Pty Ltd
See details and how to joinNCT07122258 - Phase 1/2Taking peopleA Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors
- Where
- Campbelltown, Miranda
- Age
- 18 years and over
- People
- 180 worldwide
- Run by
- Hummingbird Bioscience
See details and how to joinNCT06956690 - No phaseTaking peopleFunctional Lung Avoidance SPECT-guided Radiation Therapy of Lung Cancer
- Where
- Sydney
- Age
- 18 years and over
- People
- 90 worldwide
- Run by
- University of Aarhus
See details and how to joinNCT04676828 - Phase 2Taking peopleAPL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- Where
- Melbourne
- Age
- 18 years and over
- People
- 497 worldwide
- Run by
- Apollomics Inc.
See details and how to joinNCT03175224 · EU 2024-514542-37-00 - No phaseTaking peoplePrehabilitation for Patients Undergoing Lung Cancer Surgery
- Where
- Parkville
- Age
- 18 years and over
- People
- 25
- Run by
- University of Melbourne
See details and how to joinNCT06716437 - Phase 1Taking peopleStudy of IBI3009 in Participants with Unresectable, Metastatic or Extensive-Stage Small Cell Lung Cancer
- Where
- Heidelberg, Westmead, Wollongong
- Age
- 18 years to 75 years
- People
- 190 worldwide
- Run by
- Innovent Biologics (Suzhou) Co. Ltd.
See details and how to joinNCT06613009 · EU 2025-523972-21-00 - Phase 1Taking peopleStudy of MT-302 in Adults With Advanced or Metastatic Epithelial Tumors
- Where
- Bedford Park, Darlinghurst, Malvern, Nedlands, Randwick, Westmead
- Age
- 18 years and over
- People
- 48
- Run by
- Myeloid Therapeutics
See details and how to joinNCT05969041